Rosemary and Memory: What the Science Actually Shows

From Shakespeare to social media, rosemary has been linked to memory for centuries. Here's what the evidence actually shows — and why 2025 research has made this conversation considerably more interesting.

Originally published January 2026 · Updated April 2026 with the February 2025 Scripps Research Institute Antioxidants study on diAcCA and Alzheimer's disease, and the March 2026 Conversation review of rosemary cognition research.

"There's rosemary, that's for remembrance." Ophelia's line from Hamlet is one of the most quoted in the history of herbalism — and it turns out Shakespeare may have been onto something.

The association between rosemary and memory is ancient. Greek and Roman scholars wore rosemary garlands while studying. Medieval herbalists prescribed it for forgetfulness. The question for modern science is whether any of this folk wisdom has a biological basis — and if so, what that basis is.

The evidence has become considerably more interesting in the past year. A February 2025 study published in Antioxidants by researchers at the Scripps Research Institute found that a stable form of carnosic acid — a compound found in rosemary and sage — improved memory, increased synaptic density, and reduced Alzheimer's-related proteins in mouse models of the disease. This is not the same as proving rosemary sniffing prevents dementia. But it is meaningfully more than the viral wellness claims suggest.

Here is the honest, complete picture.

TL;DR

• Rosemary contains several biologically active compounds — most notably 1,8-cineole, carnosic acid, and rosmarinic acid — that have documented effects on brain chemistry, inflammation, and acetylcholine degradation.
• The aromatherapy evidence is real but modest: inhaling rosemary essential oil produces measurable cognitive improvements in healthy adults in controlled settings, and blood levels of 1,8-cineole correlate directly with cognitive performance — the first time this has been demonstrated in humans.
• A February 2025 Scripps Research study found that diAcCA — a stable form of carnosic acid — improved memory, increased synaptic connections, and reduced amyloid-beta and tau proteins in Alzheimer's mouse models. Human trials have not yet been conducted.
• Aromatherapy with rosemary and lemon in the morning and lavender and orange in the evening has shown significant cognitive improvement in dementia patients in one Japanese clinical study.

The honest assessment: rosemary has genuine, biologically plausible effects on cognition. It is not a treatment for dementia. The 2025 research is encouraging but at an early stage.

What Rosemary Contains That Matters

Understanding the evidence requires understanding which components of rosemary are doing what.

1,8-Cineole — also called eucalyptol — is a monoterpene found in rosemary essential oil that crosses the blood-brain barrier after inhalation. It is the primary compound responsible for the aromatherapy cognitive effects. It inhibits acetylcholinesterase — the enzyme that breaks down acetylcholine, the neurotransmitter central to memory and learning. By slowing acetylcholine breakdown, 1,8-cineole increases the availability of this neurotransmitter in synaptic connections. This is the same mechanism exploited by several approved Alzheimer's medications including donepezil and rivastigmine — though at dramatically different concentrations.

Carnosic acid — a diterpene phenol found in both rosemary and sage, with potent antioxidant and anti-inflammatory properties. Unlike 1,8-cineole, carnosic acid is not primarily an aromatherapy compound — it is most bioavailable when consumed rather than inhaled. Carnosic acid activates the Nrf2 pathway, which upregulates the body's endogenous antioxidant defence system. It also directly scavenges reactive oxygen species in brain tissue. Crucially, it appears to only become fully active in inflamed brain regions — a targeted mechanism that has attracted significant pharmaceutical interest.

Rosmarinic acid — a polyphenol found in both rosemary and other herbs including basil and mint. It has anti-inflammatory properties and has shown inhibitory effects on amyloid-beta aggregation in laboratory studies — the process by which protein plaques form in Alzheimer's disease.

Ursolic acid — a triterpenoid with emerging evidence for neuroprotective effects and inhibition of tau phosphorylation in cell studies.

These compounds act through different mechanisms and are relevant to different forms of rosemary use. The aromatherapy evidence is primarily about 1,8-cineole. The Alzheimer's drug research is primarily about carnosic acid and rosmarinic acid. Conflating the two is one of the most common errors in popular coverage of this area.

The Aromatherapy Evidence: What It Shows

The most frequently cited human study on rosemary and cognition was conducted by Mark Moss and Lorraine Oliver at Northumbria University. Researchers randomly assigned 144 healthy adult volunteers to cubicles scented with rosemary essential oil, lavender essential oil, or no scent, and had them perform a standardised cognitive test battery.

Participants exposed to rosemary showed significantly better performance on prospective memory tasks — the kind of memory involved in remembering to do things at a future time — compared to those in unscented rooms. The lavender group showed reduced alertness and impaired memory compared to controls.

What made this study particularly significant was the blood analysis. Results indicated for the first time in human subjects that concentration of 1,8-cineole in the blood is related to an individual's cognitive performance — with higher concentrations resulting in improved performance. This established the pharmacological mechanism directly in humans: 1,8-cineole inhaled from rosemary aroma reaches the bloodstream, crosses the blood-brain barrier, and produces measurable cognitive effects.

A subsequent study by the same research group found cognitive improvements in older adults exposed to rosemary aroma, though the effect sizes were smaller than in younger adults. A 2020 review of the literature concluded that rosemary is memory boosting based on the accumulated evidence.

The limitations of this evidence are important to acknowledge. The studies are relatively small, the cognitive improvements are in healthy adults rather than people with dementia, and the effect sizes — while statistically significant — are modest. This is evidence that rosemary aroma affects brain chemistry in ways consistent with improved memory performance. It is not evidence that rosemary prevents or treats dementia.

The 2025 Research: Carnosic Acid and Alzheimer's Disease

The most significant recent development is substantially more interesting than the aromatherapy literature — and represents a genuine scientific advance rather than a popular wellness story.

In 2025, researchers at the Scripps Research Institute developed diAcCA — a stable synthetic version of carnosic acid that can survive digestion and reach the brain at therapeutic concentrations. Natural carnosic acid degrades rapidly in the digestive system, limiting its bioavailability significantly. DiAcCA is protected until it reaches the gut, where it is converted to carnosic acid and absorbed.

The research, published in Antioxidants on February 28, 2025, showed that when diAcCA was used to treat mouse models of Alzheimer's disease, it achieved therapeutic doses of carnosic acid in the brain and led to enhanced memory, boosted synaptic density — the connections between brain cells — and reduced harmful Alzheimer's-related proteins including amyloid-beta and tau.

What is especially notable is the targeted mechanism: diAcCA only activates in inflamed brain regions, which could minimise side effects compared to compounds that act throughout the brain and body indiscriminately. In mouse studies, no signs of toxicity were observed.

The researchers believe diAcCA could also help treat other inflammatory conditions, including type 2 diabetes, cardiovascular disease, and Parkinson's disease — reflecting the broad anti-inflammatory pathway it activates.

This is pre-clinical research. Mouse models of Alzheimer's disease do not perfectly replicate the human condition, and the history of Alzheimer's drug development is littered with compounds that showed promise in animal models but failed in human trials. Human clinical trials for diAcCA have not yet been announced or conducted.

The honest framing: this is one of the more promising early-stage Alzheimer's research developments of 2025, and it is grounded in real biology. It is not evidence that eating rosemary or smelling rosemary oil prevents Alzheimer's disease.

The Dementia Aromatherapy Clinical Evidence

Beyond the healthy adult cognition studies, there is a small but interesting body of clinical research on aromatherapy in people with dementia specifically.

A Japanese clinical study found that aromatherapy using a mixture of lemon and rosemary essential oils in the morning — to activate the sympathetic nervous system and improve concentration — and lavender and orange oils in the evening — to activate the parasympathetic nervous system and aid sleep — produced significant improvement in cognitive function in patients with dementia. The study measured improvements on MMSE (Mini-Mental State Examination) scores.

A further study assessed the efficacy of aromatherapy with rosemary essential oil on cognition and on behavioural and psychological symptoms of dementia in patients with mild cognitive impairment and found aromatherapy to be safe and effective in this population.

These are small studies and their methodologies vary. But they are conducted in the relevant clinical population — people with mild cognitive impairment and dementia — rather than exclusively in healthy adults. The signal is consistent with the mechanism: 1,8-cineole reaches the brain via inhalation and produces acetylcholinesterase inhibition that is pharmacologically relevant to cognitive support.

Aromatherapy research in dementia populations has shown mixed but sometimes positive effects on agitation, behaviour, and cognition. Mechanisms and optimal protocols are still under study.

What Eating Rosemary Provides

The aromatherapy story is primarily about 1,8-cineole absorbed through the olfactory system. The dietary story is different — and involves the polyphenols and diterpenes that are extracted during cooking and consumed.

Dietary rosemary provides rosmarinic acid and some carnosic acid, alongside other antioxidant and anti-inflammatory compounds. The Mediterranean diet — which includes regular use of rosemary and other aromatic herbs in cooking — is consistently associated with reduced dementia risk in epidemiological studies. Disentangling the contribution of rosemary specifically from the broader dietary pattern is methodologically challenging, but the mechanistic basis for a contribution is biologically coherent.

The practical position: cooking regularly with rosemary — particularly in the context of a broader Mediterranean dietary pattern rich in olive oil, oily fish, vegetables, and legumes — contributes bioactive compounds with evidence for neuroprotective effects. This is not the same as a targeted treatment, but it is a reasonable and accessible dietary habit with no downside.

The Honest Assessment

The social media version of this story — sniff rosemary, prevent Alzheimer's — is not what the evidence supports. The scientific version is more interesting and more nuanced.

Rosemary contains biologically active compounds that cross the blood-brain barrier, inhibit acetylcholinesterase, reduce neuroinflammation, and in animal models reduce the pathological proteins associated with Alzheimer's disease. The aromatherapy evidence in healthy adults is real and mechanistically explained. The early-stage drug research based on a synthetic carnosic acid derivative is genuinely promising. The clinical aromatherapy evidence in people with dementia is small but consistent.

What the evidence does not support: that rosemary sniffing treats, prevents, or reverses dementia. That using rosemary oil provides therapeutic doses of carnosic acid — it does not, because carnosic acid is not primarily bioavailable through inhalation. That any single intervention, however biologically plausible, replaces the multifactorial approach to dementia risk reduction.

Frequently Asked Questions

Does sniffing rosemary actually improve memory?

In controlled studies with healthy adults, yes — inhaling rosemary essential oil produces measurable improvements in prospective memory tasks, and blood levels of the primary active compound 1,8-cineole correlate directly with cognitive performance. The effect sizes are modest and the research is primarily in healthy adults rather than people with dementia. The mechanism — acetylcholinesterase inhibition by 1,8-cineole — is well established.

Can rosemary prevent or treat dementia?

Not based on current evidence. The aromatherapy research demonstrates modest cognitive effects in healthy adults and some preliminary benefit in people with mild cognitive impairment. A 2025 Scripps Research study found a rosemary compound reduced Alzheimer's proteins in mouse models, but human trials have not been conducted. Rosemary is not a treatment for dementia and should not be used as a substitute for evidence-based medical care.

What is carnosic acid and why does it matter for Alzheimer's research?

Carnosic acid is an antioxidant and anti-inflammatory compound found in rosemary and sage. It activates the Nrf2 pathway — the body's endogenous antioxidant defence system — and appears to specifically target inflamed brain regions. A 2025 Scripps Research study found that a stable synthetic form of carnosic acid (diAcCA) improved memory, increased synaptic density, and reduced amyloid-beta and tau proteins in Alzheimer's mouse models. This is early-stage research, but it represents one of the more mechanistically coherent leads in Alzheimer's drug development.

Is rosemary essential oil the same as eating rosemary?

No — they deliver different compounds through different mechanisms. Rosemary essential oil used in aromatherapy primarily delivers 1,8-cineole through the olfactory system, which reaches the brain quickly. Eating rosemary delivers polyphenols including rosmarinic acid and some carnosic acid through digestion, which is a slower and differently distributed delivery route. The cognitive effects of each route are driven by different compounds operating through different mechanisms.

How should I use rosemary if I'm interested in cognitive support?

The most evidence-aligned approaches are: diffusing rosemary essential oil (look for genuine Rosmarinus officinalis oil rather than synthetic fragrance) in a workspace for potential mild cognitive support during mentally demanding tasks; and cooking regularly with rosemary as part of a broader Mediterranean dietary pattern that has consistent evidence for supporting cognitive health. Neither should be considered a treatment for any condition.

Is there any evidence for rosemary in people with dementia specifically?

A small Japanese clinical study found that a morning aromatherapy protocol including rosemary and lemon oils produced significant improvements in cognitive test scores in people with dementia. A further study found aromatherapy with rosemary essential oil to be safe and effective in people with mild cognitive impairment. These are small studies with limitations, but they are the most clinically relevant evidence available and their findings are consistent with the mechanistic picture.

The Bottom Line

The ancient association between rosemary and memory turns out to have a genuine biological basis — one that modern science is only beginning to map properly. The aromatherapy evidence is real, the 2025 carnosic acid research is promising, and the mechanistic picture is coherent.

What the evidence does not support is the viral wellness claim that sniffing rosemary prevents or treats dementia. The gap between biologically plausible and clinically proven is significant — and honest communication about where the science actually sits matters, particularly for the families and individuals affected by dementia who deserve accurate information.

Rosemary in your cooking, rosemary oil diffused in your workspace, and a Mediterranean dietary pattern that includes it regularly — these are low-risk habits with plausible cognitive benefits. They are not treatments. And the 2025 research suggests that a pharmaceutical derivative of rosemary's active compound may one day be — but that day has not yet arrived.

For a structured approach to lifestyle habits that support long-term cognitive health, the Stress Reset and Sleep Reset from the Reset Series™ address the two most evidence-backed modifiable risk factors for cognitive decline — chronic stress and poor sleep quality. Pair either with the Reset Companion for ongoing personalised support as you embed the habits.

Related reading: Mushroom Supplements: What the Science Actually Shows · Cortisol Explained — and How to Reduce It Without Making Things Worse · Social Wellness: Why Connection Is Now a Measurable Health Metric

Popular Articles